MEI Pharma Inc Cash Flow-to-Debt Ratio
MEI Pharma Inc cash flow-to-debt ratio. MEI Pharma Inc (MEIP) has a Cash Flow-to-Debt Ratio of -1.82x as of June 2025, meaning its operating cash flow of $-2.46 Million could theoretically repay -2% of its total liabilities ($1.35 Million) in one year. Check MEI Pharma Inc (MEIP) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of MEI Pharma Inc (2003–2025)
Cash flow-to-debt ratio of MEI Pharma Inc from 2003 to 2025. Historical debt coverage capacity for MEI Pharma Inc across 23 annual periods. Check MEI Pharma Inc (MEIP) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
MEI Pharma Inc Cash Flow-to-Debt Ratio by Year (2003–2025)
MEI Pharma Inc cash flow-to-debt ratio by year from 2003 to 2025. Year-by-year debt coverage analysis for MEI Pharma Inc. For the full cash flow conversion analysis, see MEIP operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -15.39x | $-20.84 Million | $1.35 Million | ▼ -154.8% |
| 2024 | -6.04x | $-50.47 Million | $8.36 Million | ▼ -1007.1% |
| 2023 | -0.55x | $-52.48 Million | $96.19 Million | ▼ -40.4% |
| 2022 | -0.39x | $-48.75 Million | $125.43 Million | ▼ -61.4% |
| 2021 | -0.24x | $-31.96 Million | $132.74 Million | ▼ -192.4% |
| 2020 | 0.26x | $34.26 Million | $131.51 Million | ▲ +130.8% |
| 2019 | -0.85x | $-29.42 Million | $34.73 Million | ▼ -115.5% |
| 2018 | -0.39x | $-21.30 Million | $54.20 Million | ▼ -154.9% |
| 2017 | 0.72x | $3.49 Million | $4.87 Million | ▲ +122.1% |
| 2016 | -3.24x | $-17.86 Million | $5.51 Million | ▲ +42.8% |
| 2015 | -5.66x | $-28.07 Million | $4.96 Million | ▼ -34.3% |
| 2014 | -4.21x | $-19.45 Million | $4.62 Million | ▲ +29.7% |
| 2013 | -6.00x | $-10.04 Million | $1.68 Million | ▼ -50.2% |
| 2012 | -3.99x | $-7.08 Million | $1.77 Million | ▼ -45.8% |
| 2011 | -2.74x | $-6.50 Million | $2.37 Million | ▲ +52.1% |
| 2010 | -5.72x | $-10.03 Million | $1.75 Million | ▼ -124.4% |
| 2009 | -2.55x | $-10.55 Million | $4.14 Million | ▲ +23.7% |
| 2008 | -3.34x | $-11.50 Million | $3.44 Million | ▲ +22.2% |
| 2007 | -4.29x | $-10.79 Million | $2.51 Million | ▲ +40.5% |
| 2006 | -7.21x | $-9.09 Million | $1.26 Million | ▼ -267.5% |
| 2005 | -1.96x | $-5.58 Million | $2.84 Million | ▲ +53.0% |
| 2004 | -4.18x | $-7.97 Million | $1.91 Million | ▼ -207.2% |
| 2003 | -1.36x | $-1.84 Million | $1.35 Million | — |